Late-Onset Sepsis in Very Low Birth Weight Infants
Overview
Authors
Affiliations
Background And Objectives: Late-onset sepsis is associated with significant morbidity and mortality among very low birth weight (VLBW) infants. Our objective was to determine risk factors associated with late-onset sepsis and to present temporal trends in overall and pathogen-specific rates.
Methods: Population-based study by the Israel Neonatal Network on VLBW infants (≤1500 g) born between 1995 and 2019. Late-onset sepsis required clinical symptoms and microbiologic confirmation. Bivariate and multivariable analyses were performed to identify risk factors. The study period was divided into 4 epochs. Overall and pathogen-specific late-onset sepsis rates for each epoch were compared.
Results: The study population comprised 31 612 VLBW infants, of whom 7423 (23.5%) had late-onset sepsis. An increased adjusted risk of late-onset sepsis was associated with gestational age <27 w (odds ratio [OR] 8.90, 95% confidence interval [CI] 7.85-10.09) and delivery room resuscitation (OR 1.43, 95% CI 1.34-1.52) and a decreased adjusted risk among infants born between 2013 and 2019 (OR 0.32, 95% CI 0.29-0.35). Late-onset sepsis rates declined from 29.5% in 1995 to 2000 to 13.0% in 2013 to 2019. Gram-negative and fungal rates decreased in all epochs, whereas gram-positive rates decreased only in the last epoch. The adjusted hazard ratios (95% CI) decreased in the 2013 to 2019 versus 1995 to 2000 epochs and were: all late-onset sepsis, 0.40 (0.37-0.43); gram-positive, 0.47 (0.37-0.59); gram- negative, 0.54 (0.48-0.61); fungal, 0.17 (0.12-0.22).
Conclusions: The strongest risk factor for late-onset sepsis was gestational age <27 w. Over a 25-year period, the pathogen-specific rates of late-onset sepsis among VLBW infants decreased approximately twofold for gram-positive and gram-negative bacterial infections and sixfold for fungal infections.
Dermitzaki N, Atzemoglou N, Giapros V, Baltogianni M, Rallis D, Gouvias T Antibiotics (Basel). 2025; 14(2).
PMID: 40001403 PMC: 11851818. DOI: 10.3390/antibiotics14020159.
Probiotics and the Risk of Infection.
Younge N, Patel R Clin Perinatol. 2025; 52(1):87-100.
PMID: 39892956 PMC: 11789005. DOI: 10.1016/j.clp.2024.10.006.
Klinger G, Reichman B, Norman M, Kusuda S, Battin M, Helenius K Neonatology. 2024; 121(6):761-771.
PMID: 38889700 PMC: 11633898. DOI: 10.1159/000539245.
Impact of sex, race, and social determinants of health on neonatal outcomes.
Alur P, Holla I, Hussain N Front Pediatr. 2024; 12:1377195.
PMID: 38655274 PMC: 11035752. DOI: 10.3389/fped.2024.1377195.